mesalamine has been researched along with tacrolimus in 20 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (15.00) | 29.6817 |
2010's | 13 (65.00) | 24.3611 |
2020's | 4 (20.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Dassopoulos, T; Hanauer, SB | 1 |
Bahador, A; Dehghani, SM; Eshraghian, A; Geramizadeh, B; Kakaei, F; Malek-Hosseini, SA | 1 |
Blumenstein, I; Bock, H; Dignass, A; Filmann, N; Hartmann, F; Herrmann, E; Schröder, O; Stein, J; Tacke, W; Zeuzem, S; Zosel, C | 1 |
Meier, J; Sturm, A | 1 |
Lubcke, R; Pan, A; Schlup, M; Schultz, M | 1 |
Indriolo, A; Ravelli, P | 1 |
Aggarwal, D; Chakraborty, S; Yadav, L | 1 |
Blasco-Alonso, J; Gallego-Gutiérrez, S; Girón Fernández-Crehuet, F; Luque Pérez, S; Navas-López, VM; Serrano Nieto, MJ; Sierra Salinas, C | 1 |
Ashizuka, S; Inatsu, H; Kita, T; Kitamura, K | 1 |
Day, AS; Eliadou, E; Gearry, RB; Inns, SJ; Rowbotham, DS; Schultz, M; Thompson-Fawcett, MW; Walmsley, R | 1 |
Grossman, AB; Maxwell, EC | 1 |
Filipec Kanizaj, T; Mijic, M | 1 |
Arisaka, O; Arisaka, T; Hiraishi, H; Irisawa, A; Kanazawa, M; Sugaya, T; Takahashi, F; Takenaka, K; Tominaga, K | 1 |
de Vries, AC; Dijkstra, G; Hansen, BE; Janneke van der Woude, C; Kreijne, JE; Lie, MRKL; Löwenberg, M; Oldenburg, B; van Assche, G; van der Meulen-de Jong, AE; van Noord, D; West, RL; Zaal, RJ | 1 |
Cordeiro, G; Dias, AM; Estevinho, MM; Magro, F | 1 |
Caron, B; Danese, S; Panaccione, R; Peyrin-Biroulet, L; Sandborn, WJ; Schreiber, S | 1 |
Aruljothy, A; Caron, B; Danese, S; Hogan, M; Jairath, V; Ma, C; MacDonald, JK; Moran, GW; Narula, N; Peyrin Biroulet, L; Singh, S; Vuyyuru, SK; Zayadi, A | 1 |
10 review(s) available for mesalamine and tacrolimus
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Evolving treatment strategies for inflammatory bowel disease.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Cyclosporins; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mesalamine; Methotrexate; Mycophenolic Acid; Steroids; Tacrolimus | 2001 |
Current treatment of ulcerative colitis.
Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal; Azathioprine; Colitis, Ulcerative; Cyclosporine; Endoscopy; Gastroenterology; Humans; Infliximab; Mercaptopurine; Mesalamine; Remission Induction; Steroids; Tacrolimus; Treatment Outcome; Tumor Necrosis Factor-alpha | 2011 |
Fulminant ulcerative colitis despite maximal immunosuppression following liver transplantation: a case report and literature review.
Topics: Cholangitis, Sclerosing; Colectomy; Colitis, Ulcerative; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Liver Transplantation; Mesalamine; Middle Aged; Mycophenolic Acid; Prednisone; Recurrence; Tacrolimus | 2011 |
Clinical management of inflammatory bowel disease in the organ recipient.
Topics: Azathioprine; Cholangitis, Sclerosing; Colectomy; Colorectal Neoplasms; End Stage Liver Disease; Graft Rejection; Heart Transplantation; Humans; Inflammatory Bowel Diseases; Kidney Transplantation; Liver Transplantation; Mesalamine; Risk Factors; Tacrolimus; Treatment Outcome; Tumor Necrosis Factor-alpha | 2014 |
Advances in Pediatric Inflammatory Bowel Disease.
Topics: Adalimumab; Adolescent; Adrenal Cortex Hormones; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Azathioprine; Colitis, Ulcerative; Crohn Disease; Enteral Nutrition; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Infliximab; Mesalamine; Methotrexate; Sulfasalazine; Tacrolimus | 2016 |
Inflammatory bowel disease in liver transplanted patients.
Topics: Algorithms; Anastomosis, Surgical; Cholangitis, Sclerosing; Colonoscopy; Colorectal Neoplasms; Female; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Liver Failure; Liver Transplantation; Male; Mesalamine; Postoperative Period; Proctocolectomy, Restorative; Risk Factors; Tacrolimus; Treatment Outcome; Tumor Necrosis Factor-alpha | 2017 |
Inflammatory Bowel Disease - Non-biological treatment.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Digestive System Surgical Procedures; Gastrointestinal Agents; Humans; Mesalamine; Methotrexate; Tacrolimus; Treatment Outcome | 2020 |
Drug development for ulcerative proctitis: current concepts.
Topics: Administration, Oral; Administration, Rectal; Adrenal Cortex Hormones; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Drug Development; Endpoint Determination; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Mesalamine; Proctitis; Randomized Controlled Trials as Topic; Sigmoidoscopy; Tacrolimus; Treatment Outcome | 2021 |
Systematic review with meta-analysis: Medical therapies for treatment of ulcerative proctitis.
Topics: Administration, Oral; Adult; Anti-Inflammatory Agents, Non-Steroidal; Budesonide; Colitis, Ulcerative; Humans; Mesalamine; Proctitis; Remission Induction; Tacrolimus | 2023 |
1 trial(s) available for mesalamine and tacrolimus
Article | Year |
---|---|
No Superiority of Tacrolimus Suppositories vs Beclomethasone Suppositories in a Randomized Trial of Patients With Refractory Ulcerative Proctitis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Beclomethasone; Colitis, Ulcerative; Female; Humans; Male; Mesalamine; Proctitis; Quality of Life; Suppositories; Tacrolimus | 2020 |
9 other study(ies) available for mesalamine and tacrolimus
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
De novo inflammatory bowel disease after pediatric orthotopic liver transplant: a case report.
Topics: Adolescent; Anti-Inflammatory Agents; Biopsy; Chronic Disease; Colitis, Ulcerative; Colon; Colonoscopy; Diarrhea; Drug Therapy, Combination; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Intestinal Mucosa; Liver Cirrhosis; Liver Transplantation; Male; Mesalamine; Mycophenolic Acid; Prednisolone; Tacrolimus; Transplantation, Homologous; Treatment Outcome | 2009 |
Female patients suffering from inflammatory bowel diseases are treated less frequently with immunosuppressive medication and have a higher disease activity: a subgroup analysis of a large multi-centre, prospective, internet-based study.
Topics: Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Budesonide; Colitis, Ulcerative; Crohn Disease; Cross-Sectional Studies; Cyclosporine; Female; Germany; Humans; Immunosuppressive Agents; Infliximab; Male; Mercaptopurine; Mesalamine; Methotrexate; Middle Aged; Practice Patterns, Physicians'; Prospective Studies; Remission Induction; Severity of Illness Index; Sex Factors; Tacrolimus | 2011 |
Prediction of in vivo drug performance using in vitro dissolution coupled with STELLA: a study with selected drug products.
Topics: Capsules; Computer Simulation; Drug Liberation; Ganciclovir; Humans; Linezolid; Mesalamine; Models, Biological; Solubility; Tablets; Tacrolimus; Valganciclovir | 2015 |
Successful treatment for ulcerative proctitis with rectal tacrolimus in an 8-year-old girl with intolerance to mesalamine.
Topics: Administration, Rectal; Anti-Inflammatory Agents, Non-Steroidal; Child; Colitis, Ulcerative; Female; Humans; Immunosuppressive Agents; Mesalamine; Proctitis; Remission Induction; Tacrolimus | 2014 |
Adrenomedullin Therapy in Patients with Refractory Ulcerative Colitis: A Case Series.
Topics: Adrenomedullin; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colitis, Ulcerative; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Mesalamine; Middle Aged; Pilot Projects; Prednisolone; Prospective Studies; Tacrolimus; Treatment Outcome; Vasodilator Agents | 2016 |
New Zealand Society of Gastroenterology Guidelines for the Management of Refractory Ulcerative Colitis.
Topics: Adalimumab; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Appendectomy; Azathioprine; Colitis, Ulcerative; Cyclosporine; Drug Resistance; Drug Therapy, Combination; Fecal Microbiota Transplantation; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Leukapheresis; Mercaptopurine; Mesalamine; Methotrexate; New Zealand; Pediatrics; Piperidines; Proctocolectomy, Restorative; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Recurrence; Severity of Illness Index; Tacrolimus; Tumor Necrosis Factor-alpha | 2015 |
Hematemesis due to Drug Allergy to Oral Prednisolone in a Patient with Ulcerative Colitis.
Topics: Administration, Oral; Adult; Anti-Inflammatory Agents; Colitis, Ulcerative; Drug Hypersensitivity; Hematemesis; Humans; Male; Mesalamine; Prednisolone; Remission Induction; Tacrolimus; Treatment Outcome | 2019 |